At close: 1:46 PM GMT+1
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Anders Ericsson | Executive Chairman of Board | -- | -- | 1970 |
Ms. Maria Alriksson | Chief Executive Officer | -- | -- | 1983 |
Associate Prof. Joen Luirink | Co-Founder & CTO | -- | -- | 1960 |
Mr. Mats Lundgren | VP of Research & Development and CSO | -- | -- | 1965 |
Abera Bioscience AB
Dragarbrunnsgatan 45
Uppsala, 753 720
Sweden
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 6
Description
Abera Bioscience AB, a platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally. The company's development platform named BERA, uses for the display of antigens at the surface of outer membrane vesicles derived from genetically optimized gram-negative bacteria. Its lead vaccine candidate is a universal pneumococcal vaccine based on the platform BERA. The company also develops projects in immuno-oncology, Chlamydia, ETEC, Covid-19, and Tuberculosis. Abera Bioscience AB was incorporated in 2012 and is based in Uppsala, Sweden.
Corporate Governance
Abera Bioscience AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
COMBI.ST CombiGene AB (publ)
2.5600
-2.29%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1372
+1.03%
ELIC.ST Elicera Therapeutics AB (publ)
1.8450
-1.60%
IRLAB-A.ST IRLAB Therapeutics AB (publ)
12.90
-1.53%
FLUI.ST Fluicell AB (publ)
0.0530
-3.99%
KAN.ST Kancera AB (publ)
1.0520
-5.05%
CELC Celcuity Inc.
12.48
+0.16%